BackSumitomo Pharma , Ltd. Overview

Sumitomo Pharma , Ltd. Total Assets

Latest total assets for SMDPY: $850B.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$851.05B
↑ 7.61% YoYΔ $60.22B vs prior year quarter

Peer trimmed avg / median

Loading

Sumitomo Pharma , Ltd. Total Assets History

Loading

Sumitomo Pharma , Ltd. vs. peers: Total Assets Comparison

Loading

Sumitomo Pharma , Ltd. Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sumitomo Pharma , Ltd. (SMDPY) FAQ

The latest total assets for SMDPY is $850B as of September 2026. That compares with $790B in the prior-year period — up 7.6% year over year. Investors often review this figure alongside Sumitomo Pharma , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, SMDPY's total assets moved from $790B to $850B — a 7.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sumitomo Pharma , Ltd.'s operating scale or balance-sheet position.

A total assets figure of $850B for SMDPY is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SMDPY's total assets ($850B), review year-over-year change from $790B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.